Publications and Digital Products

Monitoring the distribution and impact of opioid overdose reversal medications such as naloxone is essential to optimizing overdose prevention strategies and improving public health outcomes. This Statistical Data Profile, the first to use performance data from two SAMHSA grant programs, examines the distribution of FDA-approved opioid overdose reversal medications, including naloxone/Narcan. The Data Profile also presents the training of first responders, community organization staff and other individuals to administer the reversal medications and provide other support services.

Find data on the nonuse of substances among adolescents aged 12 to 17 from the 2023 National Survey on Drug Use and Health (NSDUH). Estimates include illicit drugs, alcohol, tobacco products, and nicotine vaping.

The Treatment Episode Data Set (TEDS) collects episode-level data on clients aged 12 and older receiving substance use treatment services from facilities that are licensed or certified by their respective single state agencies (SSAs). For each treatment episode, TEDS collects data on client’s characteristics, substance(s) used, the type and duration of treatment service(s) received, years of education completed, and national outcome measures (NOMs). The NOMs presented in this report include stability in housing, employment status, criminal justice involvement, social support, retention in treatment, and abstinence.